Pulse Biosciences Announces Commercial and Clinical Partnership with the Clayman Thyroid Center

Pulse Biosciences announced a commercial and clinical partnership with the Clayman Thyroid Center at the Hospital for Endocrine Surgery in Tampa, Florida. The center is now treating patients with the nPulse Vybrance System for symptomatic benign thyroid nodules as part of a controlled market development strategy, and is the only Tampa Bay Area site offering nPulse technology.

AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.